In this issue:
Risk of cardiac/vascular diseases & VTE in CLE/DLE
Daratumumab for refractory lupus nephritis
Multi-target therapy in children with lupus nephritis
Machine learning identifies clusters predictive of SLE outcomes
LLDAS with anifrolumab in SLE
TRUMP2-SLE: SLE patients’ trust in physicians
Povetacicept: an APRIL/BAFF antagonist
Predicting SLE flare with plasma mediators
Risk factors for avascular necrosis in SLE
Risk factors for CV events in SLE
Pregnancy outcomes in women with SLE
Risk of cancer & mortality in patients hospitalised with SLE
Ocular changes in SLE
Association of hydroxychloroquine dose with HFrEF in SLE
Beneficial effects of a healthy lifestyle in SLE
Please login below to download this issue (PDF)